Across TCGA pan-cancer cohorts, PHKBP1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PHKBP1’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where PHKBP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PHKBP1 is over-expressed in tumor.
BRCA and LIHC are the cancer types where PHKBP1 tumor–normal differential expression is most reproducible.